2020 American Transplant Congress
Donor-Specific Antibody Test as a Screening Tool for Stable Long-Term Kidney Transplant Recipients
1Department of Nephrology, Madison, WI, 2Department of Surgery, Madison, WI
*Purpose: Donor-specific antibody (DSA) is an established biomarker predicting antibody mediated rejection (AMR), but at substantial cost. The utility of DSA test as a screening…2020 American Transplant Congress
Delayed Graft Function Adversely Affects Long-Term Survival for Kidney Recipients after Non-Renal Solid-Organ Transplantation
Surgery, University of Wisconsin, Madison, WI
*Purpose: End-stage renal disease (ESRD) frequently develops after nonrenal solid-organ transplantation, increasing the number of patients with a prior heart, liver or lung transplant on…2020 American Transplant Congress
Safely Increasing the Number of Renal Transplants Performed in a Small Center Through the Use of Acute Kidney Injury Donors
*Purpose: New Mexico is medically underserved state with a significant end-stage renal disease population. This study aims to further demonstrate the safety of utilizing AKI…2020 American Transplant Congress
The Art Rather Than the Science of Non-HLA Antibody Mediated Rejection in Heart Transplantation: A Single Center Experience
Cardiology, Baylor University Medical Center, Dallas, TX
*Purpose: The role of non-HLA antibodies (Ab) in HLA-DSA negative antibody mediated rejection (AMR) following heart transplant (HTx) remains largely unknown.*Methods: Retrospective analysis of all…2020 American Transplant Congress
HELLP Me! My Liver Ruptured and Nobody Can Give Me Platelets: A Case Study of Liver Transplantation for Liver Rupture from HELLP Syndrome
UCHealth University of Colorado Hospital, Aurora, CO
*Purpose: Liver rupture and infarction are rare but serious complications of hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. We report successful utilization…2020 American Transplant Congress
Management of Hepatic Artery Stenosis Post Liver Transplant
Banner University Medical Center, University of Arizona College of Medicine, Phoenix, AZ
*Purpose: Hepatic Artery Stenosis (HAS) is a significant complication after liver transplantation associated with morbidity. The primary aim of this study is to determine if…2020 American Transplant Congress
Post-Transplant Renal Function in ACLF Patients Based on Pre-Transplant Severity of Renal Dysfunction without Kidney Transplant
*Purpose: It is unknown whether severity of renal dysfunction in ACLF patients impacts outcome of ACLF patients compared to those without ACLF.*Methods: In a single…2020 American Transplant Congress
Effects of Tenofovir and Entecavir on Glomerular Kidney Function in Liver Transplant Patients: A Nationwide Cohort Study
*Purpose: Entecavir and tenofovir are currently the first-line drugs in liver transplantation (LT) patients for the prevention of hepatitis B virus recurrence. Despite its proven…2020 American Transplant Congress
Hepatic Artery Thrombosis in the Modern Era of Increased Utilization of Livers from Older Donors
Johns Hopkins Hospital, Baltimore, MD
*Purpose: In a prior study using national registry data, deceased donor age greater than 50 was associated with a 35% to 61% increased risk of…2020 American Transplant Congress
Re-Transplantation Outcomes in the United States Before and after DAA-Introduction
Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The success of direct-acting antiviral (DAA) therapy has led to the widespread treatment of HCV and near-universal cure for chronically infected patients and improved…
- « Previous Page
- 1
- …
- 504
- 505
- 506
- 507
- 508
- …
- 1683
- Next Page »